Allan Mason, the former accountant to Kerry Packer, during the height of his notoriety, speaks about his best selling book and tips for cutting back tax costs.
For more information about Allan Mason and his book "Tax Secrets of the Rich" please visit: https://allanmason.com.au/
Copyright 2024 – Finance News Network
Source: Finance News Network
02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More14 Oct 2024 - Hiremii Limited (ASX:HMI) Managing Director and CEO Andrew Hornby discusses revolutionising recruitment through AI integration, touching on the company's revenue growth, international expansion, and opportunities in the resources and energy sectors.
Read More21 Apr 2025 - Navigating the FDA Process and Clinical Trial Hurdles
Read More24 Feb 2021 - Shaw and Partners Chief Investment Officer Martin Crabb provides an update on the global economy, US stimulus packages, rising bond yields and their implications for investors.
Read More12 Feb 2020 - Mayur Resources Limited (ASX:MRL) Managing Director, Paul Mulder provides an update on the company's PNG projects, which span industrial minerals, power generation, coal, copper and gold.
Read More29 Feb 2024 - Mitch Thomas - CFO - Latin Resources (ASX:LRS) is exploring and developing sustainable minerals in Australia and Latin America to provide the planet with environmentally friendly products.
Read More03 Jun 2024 - Chris Gosselin interviews Dan Nicolaides on how Digital Asset Funds Management uses crypto market volatility for stable returns and risk management.
Read More31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
